Global digital breast tomosynthesis market was valued at USD 1.41 million in 2018. It is expected to grow at a CAGR 13.5% during the forecast period. This is due to technological advances, increasing awareness about tomosynthesis and an increase in breast cancer cases around the world.
According to the World Health Organization (WHO), breast cancer afflicted approximately 627,000 women worldwide in 2018. It is also estimated that the incidence of the disease is higher in developed than in developing countries. DBT screening is more efficient and convenient than 2D mammograms. This is why there is expected to be an increase in demand for these products over the forecast period.
According to the American Journal of Roentgenology, in 2014, relative changes in recall rates were 16.1% lower for patients screened using 3D digital breasttomosynthesis (AJR) than in patients screened using 2D digital mammograms. These factors will drive market growth during the forecast period.
Market growth will also be boosted by increased awareness of the advantages of DBT over traditional systems.
According to Konica Minolta Health Americas, Inc. in 2016, the efficiency in DBT screening for invasive cancer has increased to nearly 50.0%. Digital breast tomosynthesis market growth is being driven by key companies that are investing in product and technological innovations for greater efficiency and precision. Fujifilm, for example, launched three new software tools in March 2019 for its ASPIRE Cristalle digital mammography system to improve efficiency.
The market can be divided into two types of products: standalone 3D systems and 2D/3D combination. In 2018, the most popular product segment was standalone 3D systems. The key drivers of this segment are the increasing prevalence of breast cancer around the world and increased awareness about standalone DBT 3D system. According to the American Cancer Society in the United States, there were approximately 63,410 cases in situ and 252,710 cases of breast cancer invasive in 2017.
According to Konica Minolta Healthcare Americas, Inc., standalone 3-D systems can overcome limitations of 2D mammography systems in terms precision, efficiency, as well as sensitivity. This report will propel the segment's growth. The segment 2D/3D combination system is expected to see the most growth during the forecast period. This segment is driven by rising awareness of the benefits of using these systems.
According to the American Society of Clinical Oncology's (ASCO) study, 2016 saw a decrease in the detection rate of 2D/3D combination systems by almost 28.0% and a 16.0% drop in recall rates.
The market can be divided into diagnostic centers, hospitals, and other segments based on end-use. Due to rising breast cancer prevalence and increasing healthcare spending in developing countries, the hospitals segment dominated in 2018. According to the India Brand Equity Foundation (IBEF), the Indian hospital industry will generate USD 132.84 trillion in revenue by 2022. These factors will positively influence the segment's growth during the forecast period.
The segment of diagnostics centers is expected to experience the fastest growth during the forecast period. The segment is expected to grow due to the increasing number of diagnostics centres around the world. According to the India Brand Equity Foundation in 2018, foreign direct investment (FDI), made approximately USD 6.0 billion in hospitals and diagnostics centers between April 2000-December 2018.
In 2018, North America was the dominant market for global products and will continue to be so in the future. The North American market is driven by the rising incidence of breast cancer. Market growth is expected to be driven by the strong healthcare infrastructure in the region and rising healthcare spending. Asia Pacific will be the fastest-growing region market during the forecast period, as major companies seek to enter emerging countries.
Hologic, Inc., GE Healthcare, Siemens Healthineers, Fujifilm Corp. are some of the most prominent companies in this market. To strengthen their market position, these companies have used strategies such as product development and mergers & acquisitions.
True Breast Tomosynthesis of Siemens Healthineers was approved by the FDA in April 2015. This allowed the company to expand its customer base. In September 2014, 3D Breast Imaging of GE Healthcare was approved by the FDA. This further accelerated demand for 3D Breast Tomosynthesis Imaging System.
This report provides a forecast of revenue growth at the global, regional and country level and analyzes the most recent industry trends in each sub-segment from 2014 to 2026. Grand View Research has divided the global digital breasttomosynthesis market report by product, region, and end-use.
Product Outlook (Revenue USD Million, 2014-2026)
2D/3D Combination Systems
Standalone 3D Systems
End-Use Outlook (Revenue USD Million, 2014-2026)
Hospitals
Diagnostics Centers
Other
Regional Outlook (Revenue USD Million, 2014-2026)
North America
The U.S.
Canada
Europe
The U.K.
Germany
Asia-Pacific
Japan
China
Latin America
Brazil
Mexico
MEA
South Africa
Saudi Arabia
Up Market Research published a new report titled “Digital Breast Tomosynthesis Market research report which is segmented by End Use (Diagnostic Centers, Hospitals), by Product (Standalone 3D, 2D/3D Combination), By Players/Companies merger & acquisitions, Hologic, such as product development, partnerships to strengthen their foothold in the market, Inc; GE Healthcare; Siemens Healthineers; Dexela Ltd; and Fujifilm Corp These companies have adopted strategies”. As per the study the market is expected to grow at a CAGR of XX% in the forecast period.
Report Attributes | Report Details |
Report Title | Digital Breast Tomosynthesis Market Research Report |
By End Use | Diagnostic Centers, Hospitals |
By Product | Standalone 3D, 2D/3D Combination |
By Companies | merger & acquisitions, Hologic, such as product development, partnerships to strengthen their foothold in the market, Inc; GE Healthcare; Siemens Healthineers; Dexela Ltd; and Fujifilm Corp These companies have adopted strategies |
Regions Covered | North America, Europe, APAC, Latin America, MEA |
Base Year | 2020 |
Historical Year | 2018 to 2019 (Data from 2010 can be provided as per availability) |
Forecast Year | 2028 |
Number of Pages | 242 |
Number of Tables & Figures | 170 |
Customization Available | Yes, the report can be customized as per your need. |
The report covers comprehensive data on emerging trends, market drivers, growth opportunities, and restraints that can change the market dynamics of the industry. It provides an in-depth analysis of the market segments which include products, applications, and competitor analysis.
The market is segmented by End Use (Diagnostic Centers, Hospitals), by Product (Standalone 3D, 2D/3D Combination).
Digital Breast Tomosynthesis Market research report delivers a close watch on leading competitors with strategic analysis, micro and macro market trend and scenarios, pricing analysis and a holistic overview of the market situations in the forecast period. It is a professional and a detailed report focusing on primary and secondary drivers, market share, leading segments and geographical analysis. Further, key players, major collaborations, merger & acquisitions along with trending innovation and business policies are reviewed in the report.
Key Benefits for Industry Participants & Stakeholders:
Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa (MEA). North America region is further bifurcated into countries such as U.S., and Canada. The Europe region is further categorized into U.K., France, Germany, Italy, Spain, Russia, and Rest of Europe. Asia Pacific is further segmented into China, Japan, South Korea, India, Australia, South East Asia, and Rest of Asia Pacific. Latin America region is further segmented into Brazil, Mexico, and Rest of Latin America, and the MEA region is further divided into GCC, Turkey, South Africa, and Rest of MEA.
We have studied the Digital Breast Tomosynthesis Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2028.
How you may use our products:
Reasons to Purchase the Digital Breast Tomosynthesis Market Report:
Some other reports from this category!